Natco Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|
| Revenue | 575.60 | 1,344 | 1,276.70 |
| Operating Expense | 378.20 | 501.90 | 473.90 |
| Net Profit | 124.90 | 661.10 | 636.30 |
| Net Profit Margin | 21.70 | 49.19 | 49.84 |
| Earning Per Share | 6.97 | 36.91 | 35.53 |
| EBIDTA | 199.90 | 854.10 | 813.50 |
| Effective Tax Rate | 14.13 | 17.55 | 16.49 |
| Particulars | Dec 2024 |
|---|---|
| Revenue | 575.60 |
| Operating Expense | 378.20 |
| Net Profit | 124.90 |
| Net Profit Margin | 21.70 |
| Earning Per Share | 6.97 |
| EBIDTA | 199.90 |
| Effective Tax Rate | 14.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 3,568.90 | 2,351 | 1,767.80 |
| Operating Expenses Annual | 1,931.90 | 1,506.30 | 1,554.80 |
| Operating Profit Annual | 1,741.70 | 930.20 | 307.60 |
| Interest Annual | 14.50 | 8.60 | 13.30 |
| Depreciation | 171.90 | 150.90 | 138.40 |
| Net Profit Annual | 1,306.60 | 637.10 | 139.10 |
| Tax Annual | 248.70 | 133.60 | 16.80 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 3,568.90 |
| Operating Expenses Annual | 1,931.90 |
| Operating Profit Annual | 1,741.70 |
| Interest Annual | 14.50 |
| Depreciation | 171.90 |
| Net Profit Annual | 1,306.60 |
| Tax Annual | 248.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 6.90 | 5.90 | 5.10 |
| Cash Flow from Operations | 1,196.40 | 784.40 | 57.70 |
| Cash Flow from Investing | -960.50 | -436.60 | -92.50 |
| Cash Flow from Financing | -237.30 | -346.80 | 35.60 |
| Cash Flow at the End | 5.50 | 6.90 | 5.90 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 6.90 |
| Cash Flow from Operations | 1,196.40 |
| Cash Flow from Investing | -960.50 |
| Cash Flow from Financing | -237.30 |
| Cash Flow at the End | 5.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 48.80 | 39.57 | 14.98 |
| PBIT Margin (%) | 43.99 | 33.15 | 7.16 |
| PBT Margin (%) | 40.96 | 29.30 | 6.62 |
| Net PROFIT Margin (%) | 36.61 | 27.10 | 7.87 |
| Return On Networth / Equity (%) | 25.38 | 14.33 | 2.54 |
| Return On Networth /Employed (%) | 28.58 | 16.17 | 2.77 |
| Return On Assets (%) | 23.80 | 13.28 | 3.07 |
| Total Debt / Equity (X) | 0.05 | 0.06 | 0.08 |
| Asset Turnover Ratio (%) | 0.65 | 0.49 | 0.39 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 48.80 |
| PBIT Margin (%) | 43.99 |
| PBT Margin (%) | 40.96 |
| Net PROFIT Margin (%) | 36.61 |
| Return On Networth / Equity (%) | 25.38 |
| Return On Networth /Employed (%) | 28.58 |
| Return On Assets (%) | 23.80 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 0.65 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 2,286.70 | 2,233.80 | 2,174.20 |
| Total Current Assets Annual | 3,410.40 | 2,494.70 | 2,167.70 |
| Non Current Assets Annual | 3,143.60 | 2,893.20 | 2,810.30 |
| Total Shareholders Funds Annual | 5,592.30 | 4,702 | 4,191.90 |
| Total Assets Annual | 6,554 | 5,387.90 | 4,978 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 2,286.70 |
| Total Current Assets Annual | 3,410.40 |
| Non Current Assets Annual | 3,143.60 |
| Total Shareholders Funds Annual | 5,592.30 |
| Total Assets Annual | 6,554 |
EPS (INR)
Expected
7.43
Reported
7.43
Surprise
0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by -0.08%
Mar 2024
EPS beaten by -0.08%
